Brio Health, Inc. — SEC Form D Filing
Brio Health, Inc. filed an SEC Form D on July 29, 2026, reporting $93K raised in Medical Devices.
Form D filing details
- Filing
- SEC Form D
- Filing date
- July 29, 2026
- Amount reported
- $93K
- Industry
- Medical Devices
- Website
- https://briohealthsolutions.com/
What the company does
Securities: SAFE. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Patients living with advanced heart failure face an overwhelming burden, and there is a clinical need for better treatment approaches due to the stagnation of current solutions and lack of new technologies.
Solution
BrioHealth Solutions is developing the BrioVAD® system, which is a Left Ventricular Assist System (LVAS) designed to help advanced heart failure patients live a more vibrant life.
Why now
There is a pressing clinical need for advanced treatment approaches for heart failure, and current solutions have not significantly evolved, creating an opportunity for new medical technologies like BrioVAD.
Verdict
Investors backed this because it presented a clear, critical problem space with an innovation story, not because of demonstrated product-market fit or a well-defined go-to-market. They were implicitly betting on the technical feasibility of the LVAS design and the team's ability to navigate stringent regulatory pathways, recognizing that a breakthrough device could command significant market share. The limited upside stemmed from the long development cycles, high capital requirements for trials, and potential for existing incumbents to iterate before BrioVAD achieved widespread adoption. This cleared because it was a high-need, high-impact medical device, not because it promised quick returns or low execution risk.
Source: SEC EDGAR Form D filing